Abstract
Early assessments of the spreading rate of COVID-19 were subject to significant uncertainty, as expected with limited data and difficulties in case ascertainment, but more reliable inferences can now be made. Here, we estimate from European data that COVID-19 cases are expected to double initially every three days, until social distancing interventions slow this growth, and that the impact of such measures is typically only seen nine days - i.e. three doubling times - after their implementation. We argue that such temporal patterns are more critical than precise estimates of the basic reproduction number for initiating interventions. This observation has particular implications for the low- and middle-income countries currently in the early stages of their local epidemics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
LP, HS and CO are funded by the Wellcome Trust and the Royal Society (grant 202562/Z/16/Z). KL is funded by the Wellcome Trust and Royal Society (107652/Z/15/Z) . FS is funded by the CIHR 2019 Novel Coronavirus (COVID-19) rapid research program. LC is funded by the BBSRC (grant BB/R009236/1). EF is funded by the MRC (grant MR/S020462/1). TH is supported bythe Royal Society (Grant Number INF\R2\180067) and Alan Turing Institute for Data Science and Artificial Intelligence. IH is supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response and the National Institute for Health Research Policy Research Programme in Operational Research (OPERA) and Alan Turing Institute for Data Science and Artificial Intelligence. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data and code used in this analysis is provided in the Github repository (https://github.com/thomasallanhouse/covid19-growth), with the exception of the UK onset-to-hospitalisation delay data. This data is provided by Public Health England under a data sharing agreement, and we are unable to share this data.